Annual change in bone mineral density in COPD
Goto, Kenichi Shiga University of Medical Science|Takatsuki Red Cross Hospital
Ogawa, Emiko Shiga University of Medical Science
Shimizu, Kaoruko Hokkaido University
Makita, Hironi Hokkaido University
Suzuki, Hidenobu Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Kawata, Yoshiki Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Niki, Noboru Tokushima University Tokushima University Educator and Researcher Directory KAKEN Search Researchers
Nishimura, Masaharu Hokkaido University
Nakano, Yasutaka Shiga University of Medical Science
quantitative CT analysis
low attenuation volume
Background: Osteoporosis is a well-known comorbidity in COPD. It is associated with poor health status and prognosis. Although the exact pathomechanisms are unclear, osteoporosis is suggested to be either a comorbidity due to shared risk factors with COPD or a systematic effect of COPD with a cause–effect relationship. This study aimed to evaluate whether progression of osteoporosis is synchronized with that of COPD.
Materials and methods: Data from 103 patients with COPD included in the Hokkaido COPD cohort study were analyzed. Computed tomography (CT) attenuation values of thoracic vertebrae 4, 7, and 10 were measured using custom software, and the average value (average bone density; ABD4,7,10) was calculated. The percentage of low attenuation volume (LAV%) for each patient was also calculated for evaluation of emphysematous lesions. Annual change in thoracic vertebral CT attenuation, which is strongly correlated with dual-energy X-ray absorptiometry-measured bone mineral density, was compared with that in FEV1.0 or emphysematous lesions.
Results: In the first CT data set, ABD4,7,10 was significantly correlated with age (ρ=–0.331; p=0.0006), body mass index (BMI; ρ=0.246; p=0.0136), St George’s Respiratory Questionnaire (SGRQ) activity score (ρ=–0.248; p=0.0115), eosinophil count (ρ=0.229; p=0.0198), and LAV% (ρ=–0.372; p=0.0001). However, ABD4,7,10 was not associated with FEV1.0. After adjustment for age, BMI, SGRQ activity score, and eosinophil count, no significant relationship was found between ABD4,7,10 and LAV%. Annual change in ABD4,7,10 was not associated with annual change in LAV% or FEV1.0.
Conclusion: Progression of osteoporosis and that of COPD are not directly related or synchronized with each other.
International Journal of Chronic Obstructive Pulmonary Disease
Dove Medical Press
© 2018 Goto et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
|DOI (Published Version)|
|URL ( Publisher's Version )|
copd_13_639.pdf 716 KB
Science and Technology